CNTA vs EVRG · $6.15B cap vs P/E 22, rev $5.96B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
CNTA currently screens at market cap $6.15B. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the CNTA and EVRG stock pages for the full models.
Not investment advice.